Negrophile
Pills and thrills and black films won't kill. Hang tough, children.

  • Those pains in my chest are from laughter at the figures in Stephanie Saul's New York Times article "Maker of Heart Drug Intended for Blacks Bases Price on Patients' Wealth," particularly the part about the cheapness and commonness of the two drugs that make up BiDil, as Dr. James E. Hartert is quoted: "The way I'd look at it, those individual components, if purchased generically, cost under 25 cents a tablet. That's a big difference from $1.80."
  • John Schmid's Milwaukee Journal-Sentinel article "Daring to dream again" outlines how things went from good to bad for black folks in the city and how, as the NAACP meets here this week, things may be getting better again. (The globalization frame is key. Check this quote from Harvard University professor Michael E. Porter: "I do believe that Milwaukee represents the leading example of the issues of urban core communities and the plight of African-Americans who were ill-equipped by a whole variety of reasons for this new kind of competition. Milwaukee is an interesting litmus test, and it has broader significance.")
  • Call me curious about Morgan Freeman's latest venture, as described in Saul Hansell's New York Times article "Actor, Working With Intel, Bets on Movies via Internet" Do we get Freeman a Macintel box, step back and watch him work?

  • posted in articles on July 8, 2005 2:02 AM | t (0)

    « Previous phile: When you make the decision to leave politics out of anything you do, then that's a political act in itself.

    » Next phile: Six ways of looking at a black consumer.


    Return to top of page